Recall Register

Food, drugs, devices › Beckman Coulter, Inc.

Device recall: Beckman Coulter DxI 9000 Access Immunoassay Analyzer, Catalog #C11137.

FDA enforcement event 94841 · Class II · initiated 22 May 2024 · status Ongoing

DeviceVoluntary: Firm initiated1 product recordChaska, MN

FDA enforcement event 94841 is a device recall by Beckman Coulter, Inc. of Chaska, MN, initiated 22 May 2024 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 87% of the 970 device enforcement events initiated in 2024 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Beckman Coulter, Inc. has 216 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Beckman Coulter, Inc., Chaska, MN.

Reason for recall

"The reason for this recall is Beckman Coulter has determined that when a DxI 9000 Access Immunoassay Analyzer is connected to a Laboratory Automation System (LAS); is running with the software versions 1.17 and below; and a sample tube is sent from the LAS to DxI 9000 Access Immunoassay Analyzer, an out of sequence message will be sent from the Analyzer to the LAS. This issue may result in…"

Distribution

"Worldwide distribution - US Nationwide distribution in the states of CA, FL, GA, IN, KS, ME, NH, NJ, OK, PA, and TX. The countries of Australia, Austria, Bahrain, Belgium, Brazil, Croatia, Czech…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-2544-2024Beckman Coulter DxI 9000 Access Immunoassay Analyzer, Catalog #C11137.183 devicesClass IIOngoing21 Aug 2024

Context

87%of 2024 device events are Class II970 events that year
1product record in this eventfirm median: 1
216events on this register for the firm

Other enforcement events for Beckman Coulter, Inc.

InitiatedProduct (first record)TypeClassRecords
15 Jul 2026Beckman Coulter DxC 500i Clinical Analyzer Modules using software version 1.5 or lower: 1) DxC 500 AU Module w/ISE, DxC DeviceClass II2
26 Jun 2026REF # D23352, MicroScan LabPro V5.03 Panel Update 11 (US), Electronic installed on the following instruments: - B1018-28DeviceClass II2
16 Mar 2026Access Total T4 Calibrator, Catalog No. 33805DeviceClass II1
23 Dec 2025CellMek SPS Sample Preparation System, REF: C44603, with softwareDeviceClass II1
26 Nov 2025Beckman Coulter UniCel Dxl 600, Part numbers: A71460, A71461, A30260; Immunoassay Method, Troponin SubunitDeviceClass II2
10 Nov 2025COULTER DxH Diluent, REF 628017 COULTER DxH ECO Diluent REF C67250 For use as an isotonic buffered diluent in conjunctioDeviceClass II1
7 Nov 2025Access 2 Reaction Vessels, individual, disposable, plastic tubes used to process patient, quality control and calibratioDeviceClass II1
1 Oct 2025Beckman Coulter UniCel DxI 600, Part Numbers: A71460, A30260; Photometric Chemistry AnalyzerDeviceClass II2
22 Sep 2025DxFLEX Flow Cytometer Catalog Number C78500 UDI-DI code: 15099590754013 The DxFLEX Flow Cytometer is intended for use asDeviceClass II1
19 Sep 2025DxC 500i Clinical Analyzer Modules, DxC 500 AU Module w/ISE, DxC 500i (Part Number C63522), DxC 500 AU Module, DxC 500i DeviceClass II2

All 216 events for Beckman Coulter, Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "The reason for this recall is Beckman Coulter has determined that when a DxI 9000 Access Immunoassay Analyzer is connected to a Laboratory Automation System (LAS); is running with the software versions 1.17 and below; and a sample tube is sent from the LAS to DxI 9000 Access Immunoassay Analyzer, an out of sequence message will be sent from the Analyzer to the LAS. This issue may result in…"

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide distribution - US Nationwide distribution in the states of CA, FL, GA, IN, KS, ME, NH, NJ, OK, PA, and TX. The countries of Australia, Austria, Bahrain, Belgium, Brazil, Croatia, Czech…"

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.